261 related articles for article (PubMed ID: 24218435)
1. Negative impact of β-arrestin-1 on post-myocardial infarction heart failure via cardiac and adrenal-dependent neurohormonal mechanisms.
Bathgate-Siryk A; Dabul S; Pandya K; Walklett K; Rengo G; Cannavo A; De Lucia C; Liccardo D; Gao E; Leosco D; Koch WJ; Lymperopoulos A
Hypertension; 2014 Feb; 63(2):404-12. PubMed ID: 24218435
[TBL] [Abstract][Full Text] [Related]
2. Adrenal beta-arrestin 1 inhibition in vivo attenuates post-myocardial infarction progression to heart failure and adverse remodeling via reduction of circulating aldosterone levels.
Lymperopoulos A; Rengo G; Zincarelli C; Kim J; Koch WJ
J Am Coll Cardiol; 2011 Jan; 57(3):356-65. PubMed ID: 21232674
[TBL] [Abstract][Full Text] [Related]
3. β-Arrestin2 Improves Post-Myocardial Infarction Heart Failure via Sarco(endo)plasmic Reticulum Ca
McCrink KA; Maning J; Vu A; Jafferjee M; Marrero C; Brill A; Bathgate-Siryk A; Dabul S; Koch WJ; Lymperopoulos A
Hypertension; 2017 Nov; 70(5):972-981. PubMed ID: 28874462
[TBL] [Abstract][Full Text] [Related]
4. An adrenal beta-arrestin 1-mediated signaling pathway underlies angiotensin II-induced aldosterone production in vitro and in vivo.
Lymperopoulos A; Rengo G; Zincarelli C; Kim J; Soltys S; Koch WJ
Proc Natl Acad Sci U S A; 2009 Apr; 106(14):5825-30. PubMed ID: 19289825
[TBL] [Abstract][Full Text] [Related]
5. GRK2 blockade with βARKct is essential for cardiac β2-adrenergic receptor signaling towards increased contractility.
Salazar NC; Vallejos X; Siryk A; Rengo G; Cannavo A; Liccardo D; De Lucia C; Gao E; Leosco D; Koch WJ; Lymperopoulos A
Cell Commun Signal; 2013 Aug; 11():64. PubMed ID: 23984976
[TBL] [Abstract][Full Text] [Related]
6. Quantification of beta adrenergic receptor subtypes in beta-arrestin knockout mouse airways.
Hegde A; Strachan RT; Walker JK
PLoS One; 2015; 10(2):e0116458. PubMed ID: 25658948
[TBL] [Abstract][Full Text] [Related]
7. Regulation of cardiac fibroblast-mediated maladaptive ventricular remodeling by β-arrestins.
Philip JL; Xu X; Han M; Akhter SA; Razzaque MA
PLoS One; 2019; 14(7):e0219011. PubMed ID: 31269046
[TBL] [Abstract][Full Text] [Related]
8. Pepducin-mediated cardioprotection via β-arrestin-biased β2-adrenergic receptor-specific signaling.
Grisanti LA; Thomas TP; Carter RL; de Lucia C; Gao E; Koch WJ; Benovic JL; Tilley DG
Theranostics; 2018; 8(17):4664-4678. PubMed ID: 30279730
[TBL] [Abstract][Full Text] [Related]
9. Reduction of sympathetic activity via adrenal-targeted GRK2 gene deletion attenuates heart failure progression and improves cardiac function after myocardial infarction.
Lymperopoulos A; Rengo G; Gao E; Ebert SN; Dorn GW; Koch WJ
J Biol Chem; 2010 May; 285(21):16378-86. PubMed ID: 20351116
[TBL] [Abstract][Full Text] [Related]
10. beta -Arrestins regulate protease-activated receptor-1 desensitization but not internalization or Down-regulation.
Paing MM; Stutts AB; Kohout TA; Lefkowitz RJ; Trejo J
J Biol Chem; 2002 Jan; 277(2):1292-300. PubMed ID: 11694535
[TBL] [Abstract][Full Text] [Related]
11. Beta1-adrenergic receptors stimulate cardiac contractility and CaMKII activation in vivo and enhance cardiac dysfunction following myocardial infarction.
Yoo B; Lemaire A; Mangmool S; Wolf MJ; Curcio A; Mao L; Rockman HA
Am J Physiol Heart Circ Physiol; 2009 Oct; 297(4):H1377-86. PubMed ID: 19633206
[TBL] [Abstract][Full Text] [Related]
12. Termination of protease-activated receptor-1 signaling by beta-arrestins is independent of receptor phosphorylation.
Chen CH; Paing MM; Trejo J
J Biol Chem; 2004 Mar; 279(11):10020-31. PubMed ID: 14699102
[TBL] [Abstract][Full Text] [Related]
13. Nonhematopoietic β-Arrestin-1 inhibits inflammation in a murine model of polymicrobial sepsis.
Sharma D; Packiriswamy N; Malik A; Lucas PC; Parameswaran N
Am J Pathol; 2014 Aug; 184(8):2297-309. PubMed ID: 24946011
[TBL] [Abstract][Full Text] [Related]
14. Myocardial adeno-associated virus serotype 6-betaARKct gene therapy improves cardiac function and normalizes the neurohormonal axis in chronic heart failure.
Rengo G; Lymperopoulos A; Zincarelli C; Donniacuo M; Soltys S; Rabinowitz JE; Koch WJ
Circulation; 2009 Jan; 119(1):89-98. PubMed ID: 19103992
[TBL] [Abstract][Full Text] [Related]
15. β-Arrestin-biased AT1R stimulation promotes cell survival during acute cardiac injury.
Kim KS; Abraham D; Williams B; Violin JD; Mao L; Rockman HA
Am J Physiol Heart Circ Physiol; 2012 Oct; 303(8):H1001-10. PubMed ID: 22886417
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic Targets for Treatment of Heart Failure: Focus on GRKs and β-Arrestins Affecting βAR Signaling.
Mangmool S; Parichatikanond W; Kurose H
Front Pharmacol; 2018; 9():1336. PubMed ID: 30538631
[TBL] [Abstract][Full Text] [Related]
17. betaARK1 inhibition improves survival in a mouse model of heart failure induced by myocardial infarction.
Suzuki Y; Nakano K; Sugiyama M; Imagawa J
J Cardiovasc Pharmacol; 2004 Sep; 44(3):329-34. PubMed ID: 15475830
[TBL] [Abstract][Full Text] [Related]
18. Enhanced β-adrenergic cardiac reserve in Trpm4⁻/⁻ mice with ischaemic heart failure.
Jacobs G; Oosterlinck W; Dresselaers T; Geenens R; Kerselaers S; Himmelreich U; Herijgers P; Vennekens R
Cardiovasc Res; 2015 Mar; 105(3):330-9. PubMed ID: 25600961
[TBL] [Abstract][Full Text] [Related]
19. β-arrestin2 in infiltrated macrophages inhibits excessive inflammation after myocardial infarction.
Watari K; Nakaya M; Nishida M; Kim KM; Kurose H
PLoS One; 2013; 8(7):e68351. PubMed ID: 23861891
[TBL] [Abstract][Full Text] [Related]
20. Adrenal signaling in heart failure: something more than a distant ship's smoke on the horizon.
Santulli G
Hypertension; 2014 Feb; 63(2):215-6. PubMed ID: 24218430
[No Abstract] [Full Text] [Related]
[Next] [New Search]
